Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates
PACBPacific Biosciences of California(PACB) Zacks Investment Research·2024-02-16 07:31

Pacific Biosciences of California (PACB) came out with a quarterly loss of 0.27pershareversustheZacksConsensusEstimateofalossof0.27 per share versus the Zacks Consensus Estimate of a loss of 0.31. This compares to loss of 0.35pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof12.900.35 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 12.90%. A quarter ago, it was expected that this maker of genetic analysis technology would post a loss of 0.30 per share when it actually produced a loss of $0.27, delivering a surprise of 10%. Over th ...